Thinking of joining a study?

Register your interest

NCT04272086 | RECRUITING | Fibroid Uterus


Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy
Sponsor:

Icahn School of Medicine at Mount Sinai

Information provided by (Responsible Party):

Daniel Katz

Brief Summary:

The study team will be randomizing patients presenting for open myomectomy to either received transversus abdominal plane blocks with either liposomal bupivacaine or standard bupivacaine. The study team will be analyzing the impact of local anesthetic on opiate consumption as the investigator's primary endpoint with other secondary endpoints.

Condition or disease

Fibroid Uterus

Intervention/treatment

Bupivacaine

Bupivacaine liposome

normal saline

Phase

PHASE4

Detailed Description:

After consent, patients will be randomized to either liposomal bupivacaine Transversus Abdominal Plane (TAP) vs standard bupivacaine TAP. Blocks will occur post induction and pre incision. Only the block team (not the anesthesia team nor the care team) will be unblinded and they will not have any impact on the data collection. The entire care team and the patient will be blinded. A standardized anesthetic regimen will be employed followed by a prescriptive post-operative pain management plan aimed at enhanced recovery. Patients will be followed for up to 96 hours and asked about their opiate consumption, pain scores, side effects, and recovery.

Study Type : INTERVENTIONAL
Estimated Enrollment : 140 participants
Masking : QUADRUPLE
Masking Description : The only people who will be unblinded are the members of the block team, who are not members of the care team nor the study team. They will open the envelopes, draw up the medications and cover the syringes with opaque paper such that no one can tell the contents.
Primary Purpose : TREATMENT
Official Title : Effect of Transversus Abdominal Plane Block Using Liposomal Bupivacaine Versus Standard Bupivacaine for Open Myomectomy: a Prospective Randomized Control Trial
Actual Study Start Date : 2020-11-09
Estimated Primary Completion Date : 2025-09
Estimated Study Completion Date : 2025-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 64 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Not pregnant
  • * Weight over 50kg presenting for open myomectomy
  • * No history of allergy to any study medication
  • * No history of malignant ventricular dysrhythmia, epilepsy, seizure disorder, or chronic pain syndrome other than pain from myomas
  • * No history of drug or alcohol use or abuse disorder or pre-existing liver disease.

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

Location Details

NCT04272086


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, New York

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Loading...